Top compounds associated with response to RUVBL1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	PI-103	GDSC1000	pan-cancer	AAC	0.083	0.007
mRNA	thalidomide	CTRPv2	pan-cancer	AAC	-0.15	0.007
mRNA	BRD1835	CTRPv2	pan-cancer	AAC	0.1	0.007
mRNA	BRD-K48477130	CTRPv2	pan-cancer	AAC	-0.16	0.007
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.097	0.007
mRNA	narciclasine	CTRPv2	pan-cancer	AAC	0.089	0.008
mRNA	AICAR	GDSC1000	pan-cancer	AAC	0.086	0.008
mRNA	CAY10603	GDSC1000	pan-cancer	AAC	0.08	0.008
mRNA	Docetaxel	GDSC1000	pan-cancer	AAC	0.084	0.008
mRNA	navitoclax:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.09	0.009

Download CSV